Antidepressant Response in Patients With Major Depression Exposed to NSAIDs: A Pharmacovigilance Study

被引:47
作者
Gallagher, Patience J.
Castro, Victor
Fava, Maurizio
Weilburg, Jeffrey B.
Murphy, Shawn N.
Gainer, Vivian S.
Churchill, Susanne E.
Kohane, Isaac S.
Iosifescu, Dan V.
Smoller, Jordan W.
Perlis, Roy H. [1 ]
机构
[1] Massachusetts Gen Hosp, Dept Psychiat, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA
关键词
COMORBIDITY; ENTERPRISE; BURDEN; SSRIS; CARE;
D O I
10.1176/appi.ajp.2012.11091325
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: It has been suggested that there is a mechanism by which nonsteroidal anti-inflammatory drugs (NSAIDs) may interfere with antidepressant response, and poorer outcomes among NSAID-treated patients were reported in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. To attempt to confirm this association in an independent population-based treatment cohort and explore potential confounding variables, the authors examined use of NSAIDs and related medications among 1,528 outpatients in a New England health care system. Method: Treatment outcomes were classified using a validated machine learning tool applied to electronic medical records. Logistic regression was used to examine the association between medication exposure and treatment outcomes, adjusted for potential confounding variables. To further elucidate confounding and treatment specificity of the observed effects, data from the STAR*D study were reanalyzed. Results: NSAID exposure was associated with a greater likelihood of depression classified as treatment resistant compared with depression classified as responsive to selective serotonin reuptake inhibitors (odds ratio=1.55, 95% CI=1.21-2.00). This association was apparent in the NSAIDs-only group but not in those using other agents with NSAID-like mechanisms (cyclooxygenase-2 inhibitors and salicylates). Inclusion of age, sex, ethnicity, and measures of comorbidity and health care utilization in regression models indicated confounding; association with outcome was no longer significant in fully adjusted models. Reanalysis of STAR*D results likewise identified an association in NSAIDs but not NSAID-like drugs, with more modest effects persisting after adjustment for potential confounding variables. Conclusions: These results support an association between NSAID use and poorer antidepressant outcomes in major depressive disorder but indicate that some of the observed effect may be a result of confounding. (Am J Psychiatry 2012; 169:1065-1072)
引用
收藏
页码:1065 / 1072
页数:8
相关论文
共 21 条
  • [1] Depression and pain comorbidity - A literature review
    Bair, MJ
    Robinson, RL
    Katon, W
    Kroenke, K
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (20) : 2433 - 2445
  • [2] Bliss R, 2011, P JOINT STAT M MIAM
  • [3] Rapid Identification of Myocardial Infarction Risk Associated With Diabetes Medications Using Electronic Medical Records
    Brownstein, John S.
    Murphy, Shawn N.
    Goldfine, Allison B.
    Grant, Richard W.
    Sordo, Margarita
    Gainer, Vivian
    Colecchi, Judith A.
    Dubey, Anil
    Nathan, David M.
    Glaser, John P.
    Kohane, Isaac S.
    [J]. DIABETES CARE, 2010, 33 (03) : 526 - 531
  • [4] Incident user cohort study of risk for gastrointestinal bleed and stroke in individuals with major depressive disorder treated with antidepressants
    Castro, Victor M.
    Gallagher, Patience J.
    Clements, Caitlin C.
    Murphy, Shawn N.
    Gainer, Vivian S.
    Fava, Maurizio
    Weilburg, Jeffrey B.
    Churchil, Susanne E.
    Kohane, Isaac S.
    Iosifescu, Dan V.
    Smoller, Jordan W.
    Perlis, Roy H.
    [J]. BMJ OPEN, 2012, 2 (02):
  • [5] VALIDATION OF A COMBINED COMORBIDITY INDEX
    CHARLSON, M
    SZATROWSKI, TP
    PETERSON, J
    GOLD, J
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1994, 47 (11) : 1245 - 1251
  • [6] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383
  • [7] Gibson TB, 2010, AM J MANAG CARE, V16, P370
  • [8] Hamilton M., 1967, Br J Soc Clin Psychol, V6, P278, DOI 10.1111/j.2044-8260.1967.tb00530.x
  • [9] IMS, 2009, US SAL PRESCR INF IM
  • [10] The impact of medical comorbidity on acute treatment in major depressive disorder
    Iosifescu, DV
    Nierenberg, AA
    Alpert, JE
    Smith, M
    Bitran, S
    Dording, C
    Fava, M
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (12) : 2122 - 2127